
### [MONDO:0018796](http://purl.obolibrary.org/obo/MONDO_0018796)
**Label:** isolated constitutional thrombocytopenia

**Subclasses:** [MONDO:0017057](http://purl.obolibrary.org/obo/MONDO_0017057) (hereditary thrombocytopenia with normal platelets), [MONDO:0009276](http://purl.obolibrary.org/obo/MONDO_0009276) (Bernard-Soulier syndrome), [MONDO:0007686](http://purl.obolibrary.org/obo/MONDO_0007686) (gray platelet syndrome), [MONDO:0015372](http://purl.obolibrary.org/obo/MONDO_0015372) (autosomal dominant macrothrombocytopenia), [MONDO:0016361](http://purl.obolibrary.org/obo/MONDO_0016361) (isolated hereditary giant platelet disorder), [MONDO:0011071](http://purl.obolibrary.org/obo/MONDO_0011071) (hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome), [MONDO:0015679](http://purl.obolibrary.org/obo/MONDO_0015679) (autosomal thrombocytopenia with normal platelets), [MONDO:0020117](http://purl.obolibrary.org/obo/MONDO_0020117) (alpha granule disease), 

**Corr. equiv. classes:** [OMIM:139090](http://purl.obolibrary.org/obo/OMIM_139090), [Orphanet:220452](http://www.orpha.net/ORDO/Orphanet_220452), [Orphanet:268322](http://www.orpha.net/ORDO/Orphanet_268322), [Orphanet:168629](http://www.orpha.net/ORDO/Orphanet_168629), [OMIM:231200](http://purl.obolibrary.org/obo/OMIM_231200), [Orphanet:274](http://www.orpha.net/ORDO/Orphanet_274), [OMIM:601399](http://purl.obolibrary.org/obo/OMIM_601399), [Orphanet:71290](http://www.orpha.net/ORDO/Orphanet_71290), [Orphanet:98455](http://www.orpha.net/ORDO/Orphanet_98455), [Orphanet:140957](http://www.orpha.net/ORDO/Orphanet_140957), [Orphanet:721](http://www.orpha.net/ORDO/Orphanet_721), 

**Class expressions from DL-Learner:**

- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001933](http://purl.obolibrary.org/obo/HP_0001933) (Subcutaneous hemorrhage) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 56.94%


